Alumis Inc. Common Stock
ALMSNASDAQHealthcare● Active
$18.99
$-0.07(-0.37%)
Market Cap$2.3B
P/E Ratio—
52W High$30.6
52W Low$2.76
Alumis Inc. Common Stock (ALMS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALMS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.74
Est. -$0.79 · +6.3%
Revenue
$0.00B
Est. $0.00B · -15.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 2-Quarter EPS Beat Streak
ALMS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.70 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$0.79 | -$0.74 | +6.3% | $0.00B | $0.00B | -15.4% |
| ▲ Q1 FY2026 | Mar 19, 2026 | -$0.97 | -$0.95 | +2.1% | $0.00B | $0.00B | -18.4% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.92 | -$1.06 | -15.2% | $0.00B | $0.00B | -24.9% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$1.11 | -$1.17 | -5.4% | $0.00B | $0.00B | -15.2% |
| ▼ Q2 FY2025 | May 14, 2025 | -$1.47 | -$1.82 | -23.8% | $0.02B | $0.00B | +943.3% |
| ▲ Q1 FY2025 | Mar 19, 2025 | -$1.40 | -$0.23 | +83.6% | $0.00B | $0.00B | +51.8% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$1.64 | -$1.73 | -5.5% | — | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.70
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$0.74
EPS Est.
-$0.79
EPS Surpr.
+6.3%
Revenue
$0.00B
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
-$0.95
EPS Est.
-$0.97
EPS Surpr.
+2.1%
Revenue
$0.00B
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$1.06
EPS Est.
-$0.92
EPS Surpr.
-15.2%
Revenue
$0.00B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$1.17
EPS Est.
-$1.11
EPS Surpr.
-5.4%
Revenue
$0.00B
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$1.82
EPS Est.
-$1.47
EPS Surpr.
-23.8%
Revenue
$0.02B
Q1 FY2025
Mar 19, 2025Beat
EPS Actual
-$0.23
EPS Est.
-$1.40
EPS Surpr.
+83.6%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$1.73
EPS Est.
-$1.64
EPS Surpr.
-5.5%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.79 | $-0.59 | $-0.40 | 1 |
| Q3 FY2027 | $-0.85 | $-0.64 | $-0.43 | 1 |
| Q2 FY2027 | $-0.87 | $-0.66 | $-0.44 | 1 |
| Q1 FY2027 | $-0.87 | $-0.66 | $-0.44 | 1 |
| Q4 FY2026 | $-0.92 | $-0.70 | $-0.47 | 1 |
| Q3 FY2026 | $-0.79 | $-0.71 | $-0.65 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +6.3% | $24.86 | $24.63 | -0.93% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +2.1% | $25.42 | $25.38 | -0.16% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -15.2% | $5.24 | $5.28 | +0.76% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -5.4% | $4.46 | $4.42 | -0.90% |
| ▼ Q2 FY2025 | May 14, 2025 | -23.8% | $4.46 | $4.51 | +1.12% |
| ▲ Q1 FY2025 | Mar 19, 2025 | +83.6% | $4.48 | $4.37 | -2.46% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -5.5% | $11.35 | $10.81 | -4.76% |
| ▼ Q3 FY2024 | Aug 13, 2024 | -413.3% | $11.99 | $12.54 | +4.59% |
Q2 FY2026-0.93%
Report Date
May 14, 2026
EPS Beat/Miss
+6.3%
Price Before
$24.86
Price After
$24.63
Q1 FY2026-0.16%
Report Date
Mar 19, 2026
EPS Beat/Miss
+2.1%
Price Before
$25.42
Price After
$25.38
Q4 FY2025+0.76%
Report Date
Nov 13, 2025
EPS Beat/Miss
-15.2%
Price Before
$5.24
Price After
$5.28
Q3 FY2025-0.90%
Report Date
Aug 13, 2025
EPS Beat/Miss
-5.4%
Price Before
$4.46
Price After
$4.42
Q2 FY2025+1.12%
Report Date
May 14, 2025
EPS Beat/Miss
-23.8%
Price Before
$4.46
Price After
$4.51
Q1 FY2025-2.46%
Report Date
Mar 19, 2025
EPS Beat/Miss
+83.6%
Price Before
$4.48
Price After
$4.37
Q4 FY2024-4.76%
Report Date
Nov 13, 2024
EPS Beat/Miss
-5.5%
Price Before
$11.35
Price After
$10.81
Q3 FY2024+4.59%
Report Date
Aug 13, 2024
EPS Beat/Miss
-413.3%
Price Before
$11.99
Price After
$12.54
Avg Beat Reaction-1.18%
Avg Miss Reaction+0.16%
Beat Rate3 / 8 quarters
Largest Move-4.76% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALMS ends December
Alumis Inc. Common Stock (ALMS) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.74 — beating the analyst consensus of $-0.79 by +6.3%. ALMS has beaten EPS estimates for 2 consecutive quarters. The next ALMS earnings date is expected around September 1, 2026.
Each quarter, investors track ALMS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALMS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALMS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALMS earnings · 5 questionsAlumis Inc. Common Stock's next earnings report is expected around September 1, 2026. ALMS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALMS historically reports after market close (AMC).
ALMS earnings datewhen is ALMS earningsALMS next earnings datewhen does ALMS report earningsALMS earnings calendar
▸ Source: FMP · Alumis Inc. Common Stock SEC filings · US GAAP · Alumis Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026